Cocrystal Pharma, Inc.
COCP
$1.24
$0.065.09%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -9.94M | -8.83M | -8.83M | -9.67M | -12.56M |
| Total Depreciation and Amortization | 50.00K | 59.00K | 72.00K | 87.00K | 104.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 431.00K | 428.00K | 421.00K | 455.00K | 687.00K |
| Change in Net Operating Assets | 1.50M | 749.00K | 146.00K | -487.00K | -1.61M |
| Cash from Operations | -7.95M | -7.59M | -8.19M | -9.62M | -13.38M |
| Capital Expenditure | -12.00K | -12.00K | -12.00K | -12.00K | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -12.00K | -12.00K | -12.00K | -12.00K | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5.37M | 5.37M | 5.37M | 4.34M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 5.37M | 5.37M | 5.37M | 4.34M | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.60M | -2.24M | -2.84M | -5.29M | -13.38M |